nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP11A1—Saquinavir—acquired immunodeficiency syndrome	0.211	0.254	CbGbCtD
Aminoglutethimide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.04	0.0481	CbGbCtD
Aminoglutethimide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0376	0.0452	CbGbCtD
Aminoglutethimide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0369	0.0443	CbGbCtD
Aminoglutethimide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0347	0.0417	CbGbCtD
Aminoglutethimide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0347	0.0417	CbGbCtD
Aminoglutethimide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.034	0.0409	CbGbCtD
Aminoglutethimide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.034	0.0409	CbGbCtD
Aminoglutethimide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0314	0.0377	CbGbCtD
Aminoglutethimide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0293	0.0353	CbGbCtD
Aminoglutethimide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0285	0.0342	CbGbCtD
Aminoglutethimide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0263	0.0316	CbGbCtD
Aminoglutethimide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0258	0.031	CbGbCtD
Aminoglutethimide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0258	0.031	CbGbCtD
Aminoglutethimide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0247	0.0297	CbGbCtD
Aminoglutethimide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0238	0.0286	CbGbCtD
Aminoglutethimide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0193	0.0232	CbGbCtD
Aminoglutethimide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0182	0.0218	CbGbCtD
Aminoglutethimide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0182	0.0218	CbGbCtD
Aminoglutethimide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0164	0.0198	CbGbCtD
Aminoglutethimide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0164	0.0198	CbGbCtD
Aminoglutethimide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0142	0.0171	CbGbCtD
Aminoglutethimide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0138	0.0166	CbGbCtD
Aminoglutethimide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.015	CbGbCtD
Aminoglutethimide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.015	CbGbCtD
Aminoglutethimide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.0144	CbGbCtD
Aminoglutethimide—Adrenal insufficiency—Ritonavir—acquired immunodeficiency syndrome	0.00632	0.0428	CcSEcCtD
Aminoglutethimide—CYP19A1—semen—acquired immunodeficiency syndrome	0.00541	0.261	CbGeAlD
Aminoglutethimide—Hepatotoxicity—Didanosine—acquired immunodeficiency syndrome	0.00292	0.0198	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Nevirapine—acquired immunodeficiency syndrome	0.00263	0.0178	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Stavudine—acquired immunodeficiency syndrome	0.00254	0.0172	CcSEcCtD
Aminoglutethimide—Hypothyroidism—Saquinavir—acquired immunodeficiency syndrome	0.00199	0.0134	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Efavirenz—acquired immunodeficiency syndrome	0.00194	0.0131	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.0116	CcSEcCtD
Aminoglutethimide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00162	0.0779	CbGeAlD
Aminoglutethimide—Neutropenia—Amprenavir—acquired immunodeficiency syndrome	0.00145	0.00984	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00928	CcSEcCtD
Aminoglutethimide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00132	0.0636	CbGeAlD
Aminoglutethimide—Haemolytic anaemia—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00863	CcSEcCtD
Aminoglutethimide—Neutropenia—Nevirapine—acquired immunodeficiency syndrome	0.00119	0.00806	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.00118	0.00798	CcSEcCtD
Aminoglutethimide—Neutropenia—Nelfinavir—acquired immunodeficiency syndrome	0.00115	0.00781	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.0078	CcSEcCtD
Aminoglutethimide—Neutropenia—Stavudine—acquired immunodeficiency syndrome	0.00115	0.00779	CcSEcCtD
Aminoglutethimide—Neutropenia—Abacavir—acquired immunodeficiency syndrome	0.00113	0.00767	CcSEcCtD
Aminoglutethimide—CYP11A1—blood—acquired immunodeficiency syndrome	0.00111	0.0536	CbGeAlD
Aminoglutethimide—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.00106	0.00718	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00694	CcSEcCtD
Aminoglutethimide—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00687	CcSEcCtD
Aminoglutethimide—Neutropenia—Zidovudine—acquired immunodeficiency syndrome	0.001	0.00677	CcSEcCtD
Aminoglutethimide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000956	0.0461	CbGeAlD
Aminoglutethimide—Myalgia—Amprenavir—acquired immunodeficiency syndrome	0.000922	0.00624	CcSEcCtD
Aminoglutethimide—Anaemia—Didanosine—acquired immunodeficiency syndrome	0.000912	0.00618	CcSEcCtD
Aminoglutethimide—CYP11A1—nervous system—acquired immunodeficiency syndrome	0.000902	0.0435	CbGeAlD
Aminoglutethimide—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000892	0.00604	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.00089	0.00602	CcSEcCtD
Aminoglutethimide—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.000884	0.00598	CcSEcCtD
Aminoglutethimide—CYP11A1—central nervous system—acquired immunodeficiency syndrome	0.000869	0.0419	CbGeAlD
Aminoglutethimide—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000854	0.00578	CcSEcCtD
Aminoglutethimide—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.000842	0.0057	CcSEcCtD
Aminoglutethimide—Neutropenia—Delavirdine—acquired immunodeficiency syndrome	0.00084	0.00569	CcSEcCtD
Aminoglutethimide—Myalgia—Didanosine—acquired immunodeficiency syndrome	0.00084	0.00569	CcSEcCtD
Aminoglutethimide—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.000838	0.00567	CcSEcCtD
Aminoglutethimide—Anaemia—Nevirapine—acquired immunodeficiency syndrome	0.00082	0.00555	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.000805	0.00545	CcSEcCtD
Aminoglutethimide—Anaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000795	0.00538	CcSEcCtD
Aminoglutethimide—Anaemia—Stavudine—acquired immunodeficiency syndrome	0.000792	0.00536	CcSEcCtD
Aminoglutethimide—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.00078	0.00528	CcSEcCtD
Aminoglutethimide—Neutropenia—Ritonavir—acquired immunodeficiency syndrome	0.000777	0.00526	CcSEcCtD
Aminoglutethimide—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00077	0.00521	CcSEcCtD
Aminoglutethimide—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.000768	0.0052	CcSEcCtD
Aminoglutethimide—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.000768	0.0052	CcSEcCtD
Aminoglutethimide—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000767	0.00519	CcSEcCtD
Aminoglutethimide—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00076	0.00514	CcSEcCtD
Aminoglutethimide—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000756	0.00512	CcSEcCtD
Aminoglutethimide—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.000756	0.00512	CcSEcCtD
Aminoglutethimide—Neutropenia—Saquinavir—acquired immunodeficiency syndrome	0.000748	0.00506	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000734	0.00497	CcSEcCtD
Aminoglutethimide—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.000732	0.00495	CcSEcCtD
Aminoglutethimide—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.00073	0.00494	CcSEcCtD
Aminoglutethimide—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000725	0.00491	CcSEcCtD
Aminoglutethimide—CYP19A1—blood—acquired immunodeficiency syndrome	0.000722	0.0348	CbGeAlD
Aminoglutethimide—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.000719	0.00487	CcSEcCtD
Aminoglutethimide—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000714	0.00483	CcSEcCtD
Aminoglutethimide—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.0007	0.00474	CcSEcCtD
Aminoglutethimide—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000691	0.00467	CcSEcCtD
Aminoglutethimide—CYP11A1—brain—acquired immunodeficiency syndrome	0.00069	0.0332	CbGeAlD
Aminoglutethimide—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000688	0.00466	CcSEcCtD
Aminoglutethimide—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000669	0.00453	CcSEcCtD
Aminoglutethimide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000667	0.00451	CcSEcCtD
Aminoglutethimide—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000667	0.00451	CcSEcCtD
Aminoglutethimide—CYP11A1—lymph node—acquired immunodeficiency syndrome	0.000666	0.0321	CbGeAlD
Aminoglutethimide—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00066	0.00447	CcSEcCtD
Aminoglutethimide—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000657	0.00445	CcSEcCtD
Aminoglutethimide—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000644	0.00436	CcSEcCtD
Aminoglutethimide—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000644	0.00436	CcSEcCtD
Aminoglutethimide—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.00064	0.00433	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000639	0.00433	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000637	0.00431	CcSEcCtD
Aminoglutethimide—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000637	0.00431	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000635	0.0043	CcSEcCtD
Aminoglutethimide—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000634	0.00429	CcSEcCtD
Aminoglutethimide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00063	0.00426	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000628	0.00425	CcSEcCtD
Aminoglutethimide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000625	0.00423	CcSEcCtD
Aminoglutethimide—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000624	0.00422	CcSEcCtD
Aminoglutethimide—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000622	0.00421	CcSEcCtD
Aminoglutethimide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000622	0.03	CbGeAlD
Aminoglutethimide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.00061	0.00413	CcSEcCtD
Aminoglutethimide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000608	0.00412	CcSEcCtD
Aminoglutethimide—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000605	0.0041	CcSEcCtD
Aminoglutethimide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000599	0.00406	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000594	0.00402	CcSEcCtD
Aminoglutethimide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000592	0.0285	CbGeAlD
Aminoglutethimide—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00059	0.00399	CcSEcCtD
Aminoglutethimide—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000586	0.0282	CbGeAlD
Aminoglutethimide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00058	0.00392	CcSEcCtD
Aminoglutethimide—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000579	0.00392	CcSEcCtD
Aminoglutethimide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000576	0.0039	CcSEcCtD
Aminoglutethimide—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000573	0.00388	CcSEcCtD
Aminoglutethimide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00057	0.00386	CcSEcCtD
Aminoglutethimide—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000564	0.0272	CbGeAlD
Aminoglutethimide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000562	0.0038	CcSEcCtD
Aminoglutethimide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000561	0.00379	CcSEcCtD
Aminoglutethimide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000557	0.00377	CcSEcCtD
Aminoglutethimide—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000557	0.00377	CcSEcCtD
Aminoglutethimide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000557	0.00377	CcSEcCtD
Aminoglutethimide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000557	0.00377	CcSEcCtD
Aminoglutethimide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000556	0.00376	CcSEcCtD
Aminoglutethimide—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000555	0.00375	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000554	0.00375	CcSEcCtD
Aminoglutethimide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000554	0.00375	CcSEcCtD
Aminoglutethimide—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000553	0.00374	CcSEcCtD
Aminoglutethimide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000549	0.0265	CbGeAlD
Aminoglutethimide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000547	0.00371	CcSEcCtD
Aminoglutethimide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000545	0.00369	CcSEcCtD
Aminoglutethimide—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00054	0.00366	CcSEcCtD
Aminoglutethimide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000539	0.00365	CcSEcCtD
Aminoglutethimide—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000535	0.00362	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000534	0.00361	CcSEcCtD
Aminoglutethimide—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000533	0.00361	CcSEcCtD
Aminoglutethimide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000528	0.00358	CcSEcCtD
Aminoglutethimide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000525	0.00355	CcSEcCtD
Aminoglutethimide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000521	0.00353	CcSEcCtD
Aminoglutethimide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000518	0.00351	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000517	0.0035	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000515	0.00349	CcSEcCtD
Aminoglutethimide—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000515	0.00349	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000515	0.00349	CcSEcCtD
Aminoglutethimide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000513	0.00347	CcSEcCtD
Aminoglutethimide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000512	0.00347	CcSEcCtD
Aminoglutethimide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000509	0.00345	CcSEcCtD
Aminoglutethimide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000508	0.00344	CcSEcCtD
Aminoglutethimide—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000508	0.0245	CbGeAlD
Aminoglutethimide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000508	0.00344	CcSEcCtD
Aminoglutethimide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000508	0.00344	CcSEcCtD
Aminoglutethimide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000505	0.00342	CcSEcCtD
Aminoglutethimide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000503	0.0034	CcSEcCtD
Aminoglutethimide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000499	0.00338	CcSEcCtD
Aminoglutethimide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.00338	CcSEcCtD
Aminoglutethimide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000496	0.00336	CcSEcCtD
Aminoglutethimide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000495	0.00335	CcSEcCtD
Aminoglutethimide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000493	0.00334	CcSEcCtD
Aminoglutethimide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000491	0.00333	CcSEcCtD
Aminoglutethimide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000491	0.00333	CcSEcCtD
Aminoglutethimide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000488	0.0033	CcSEcCtD
Aminoglutethimide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000487	0.0033	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000487	0.00329	CcSEcCtD
Aminoglutethimide—CYP1A2—blood—acquired immunodeficiency syndrome	0.000484	0.0233	CbGeAlD
Aminoglutethimide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000483	0.00327	CcSEcCtD
Aminoglutethimide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000481	0.00325	CcSEcCtD
Aminoglutethimide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000479	0.00324	CcSEcCtD
Aminoglutethimide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000478	0.00323	CcSEcCtD
Aminoglutethimide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000476	0.00322	CcSEcCtD
Aminoglutethimide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00321	CcSEcCtD
Aminoglutethimide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000475	0.00321	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000466	0.00315	CcSEcCtD
Aminoglutethimide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000464	0.00314	CcSEcCtD
Aminoglutethimide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000464	0.00314	CcSEcCtD
Aminoglutethimide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000463	0.00313	CcSEcCtD
Aminoglutethimide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000461	0.00312	CcSEcCtD
Aminoglutethimide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000461	0.00312	CcSEcCtD
Aminoglutethimide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000457	0.00309	CcSEcCtD
Aminoglutethimide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000456	0.00309	CcSEcCtD
Aminoglutethimide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000456	0.00308	CcSEcCtD
Aminoglutethimide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.00308	CcSEcCtD
Aminoglutethimide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000454	0.00307	CcSEcCtD
Aminoglutethimide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.00306	CcSEcCtD
Aminoglutethimide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000451	0.00305	CcSEcCtD
Aminoglutethimide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000449	0.00304	CcSEcCtD
Aminoglutethimide—CYP19A1—brain—acquired immunodeficiency syndrome	0.000448	0.0216	CbGeAlD
Aminoglutethimide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000447	0.00303	CcSEcCtD
Aminoglutethimide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000446	0.00302	CcSEcCtD
Aminoglutethimide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000445	0.00301	CcSEcCtD
Aminoglutethimide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000444	0.00301	CcSEcCtD
Aminoglutethimide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000442	0.00299	CcSEcCtD
Aminoglutethimide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000442	0.00299	CcSEcCtD
Aminoglutethimide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000442	0.00299	CcSEcCtD
Aminoglutethimide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000441	0.00299	CcSEcCtD
Aminoglutethimide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000441	0.00298	CcSEcCtD
Aminoglutethimide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00044	0.00298	CcSEcCtD
Aminoglutethimide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000438	0.00297	CcSEcCtD
Aminoglutethimide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000438	0.00297	CcSEcCtD
Aminoglutethimide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000434	0.00294	CcSEcCtD
Aminoglutethimide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000434	0.00294	CcSEcCtD
Aminoglutethimide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.00294	CcSEcCtD
Aminoglutethimide—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.000433	0.0209	CbGeAlD
Aminoglutethimide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000432	0.00292	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.00292	CcSEcCtD
Aminoglutethimide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00043	0.00291	CcSEcCtD
Aminoglutethimide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00043	0.00291	CcSEcCtD
Aminoglutethimide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.00288	CcSEcCtD
Aminoglutethimide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.00287	CcSEcCtD
Aminoglutethimide—CYP1A2—lung—acquired immunodeficiency syndrome	0.000424	0.0204	CbGeAlD
Aminoglutethimide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000422	0.00286	CcSEcCtD
Aminoglutethimide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00284	CcSEcCtD
Aminoglutethimide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000417	0.00282	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000417	0.00282	CcSEcCtD
Aminoglutethimide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000415	0.00281	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00281	CcSEcCtD
Aminoglutethimide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.0028	CcSEcCtD
Aminoglutethimide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000411	0.00278	CcSEcCtD
Aminoglutethimide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000409	0.00277	CcSEcCtD
Aminoglutethimide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000406	0.00275	CcSEcCtD
Aminoglutethimide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000406	0.00275	CcSEcCtD
Aminoglutethimide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00274	CcSEcCtD
Aminoglutethimide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000404	0.00274	CcSEcCtD
Aminoglutethimide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000402	0.00272	CcSEcCtD
Aminoglutethimide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.0004	0.00271	CcSEcCtD
Aminoglutethimide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000395	0.00268	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00268	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000394	0.00266	CcSEcCtD
Aminoglutethimide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000387	0.00262	CcSEcCtD
Aminoglutethimide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.00261	CcSEcCtD
Aminoglutethimide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000383	0.00259	CcSEcCtD
Aminoglutethimide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000383	0.00259	CcSEcCtD
Aminoglutethimide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000381	0.00258	CcSEcCtD
Aminoglutethimide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.00256	CcSEcCtD
Aminoglutethimide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000377	0.00255	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.00255	CcSEcCtD
Aminoglutethimide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00254	CcSEcCtD
Aminoglutethimide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000374	0.00253	CcSEcCtD
Aminoglutethimide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000374	0.00253	CcSEcCtD
Aminoglutethimide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000368	0.0177	CbGeAlD
Aminoglutethimide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.00245	CcSEcCtD
Aminoglutethimide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.00245	CcSEcCtD
Aminoglutethimide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.00244	CcSEcCtD
Aminoglutethimide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00243	CcSEcCtD
Aminoglutethimide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000359	0.00243	CcSEcCtD
Aminoglutethimide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00241	CcSEcCtD
Aminoglutethimide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00241	CcSEcCtD
Aminoglutethimide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000354	0.0024	CcSEcCtD
Aminoglutethimide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000353	0.00239	CcSEcCtD
Aminoglutethimide—CYP3A4—blood—acquired immunodeficiency syndrome	0.00035	0.0169	CbGeAlD
Aminoglutethimide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.00236	CcSEcCtD
Aminoglutethimide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.00233	CcSEcCtD
Aminoglutethimide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.00232	CcSEcCtD
Aminoglutethimide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.0023	CcSEcCtD
Aminoglutethimide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00229	CcSEcCtD
Aminoglutethimide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.00228	CcSEcCtD
Aminoglutethimide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.00228	CcSEcCtD
Aminoglutethimide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00227	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.00227	CcSEcCtD
Aminoglutethimide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000335	0.00227	CcSEcCtD
Aminoglutethimide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000334	0.00226	CcSEcCtD
Aminoglutethimide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000325	0.0022	CcSEcCtD
Aminoglutethimide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00218	CcSEcCtD
Aminoglutethimide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00218	CcSEcCtD
Aminoglutethimide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00218	CcSEcCtD
Aminoglutethimide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.00217	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.00216	CcSEcCtD
Aminoglutethimide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.00215	CcSEcCtD
Aminoglutethimide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00212	CcSEcCtD
Aminoglutethimide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.00208	CcSEcCtD
Aminoglutethimide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00206	CcSEcCtD
Aminoglutethimide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00204	CcSEcCtD
Aminoglutethimide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00203	CcSEcCtD
Aminoglutethimide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00202	CcSEcCtD
Aminoglutethimide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00202	CcSEcCtD
Aminoglutethimide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.002	CcSEcCtD
Aminoglutethimide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00196	CcSEcCtD
Aminoglutethimide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00194	CcSEcCtD
Aminoglutethimide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00194	CcSEcCtD
Aminoglutethimide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00194	CcSEcCtD
Aminoglutethimide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.00193	CcSEcCtD
Aminoglutethimide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000284	0.0137	CbGeAlD
Aminoglutethimide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.0019	CcSEcCtD
Aminoglutethimide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00187	CcSEcCtD
Aminoglutethimide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000274	0.0132	CbGeAlD
Aminoglutethimide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00185	CcSEcCtD
Aminoglutethimide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00185	CcSEcCtD
Aminoglutethimide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.00184	CcSEcCtD
Aminoglutethimide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00183	CcSEcCtD
Aminoglutethimide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00175	CcSEcCtD
